RBM25 activators are a class of chemicals that can indirectly enhance the function of the RNA-binding protein RBM25. These chemicals impact various signaling pathways or cellular processes that RBM25 is involved in, thereby influencing its activity. For instance, Anisomycin, a protein synthesis inhibitor, triggers the JNK and p38 MAPK pathways, which RBM25 is associated with, leading to enhanced functionality of RBM25. Thapsigargin, another RBM25 activator, is a potent inhibitor of SERCA and induces ER stress, activating the unfolded protein response pathway and hence indirectly enhancing the function of RBM25.
Another compound, Rapamycin, an mTOR inhibitor, indirectly influences RBM25 by impacting cellular growth and proliferation pathways. Forskolin, an activator of adenylate cyclase, increases the level of cAMP, regulating several physiological responses. Given that RBM25 is implicated in cAMP-dependent signaling pathways, Forskolin indirectly boosts the function of RBM25. Furthermore, Resveratrol, a natural polyphenol, activates Sirtuin 1, an enzyme associated with cellular stress response, indirectly enhancing RBM25 function. Genistein, a tyrosine kinase inhibitor, can influence the PI3K/Akt pathway, where RBM25 operates, thereby indirectly enhancing RBM25 functionality. Staurosporine, a potent protein kinase inhibitor, indirectly enhances RBM25 by modifying protein kinase signaling. Trichostatin A, a histone deacetylase inhibitor, by altering the acetylation state of histones, influences the expression of downstream genes including RBM25, thereby indirectly enhancing its function. LY294002, a potent PI3K inhibitor, indirectly enhances the function of RBM25 by inhibiting PI3K, a pathway in which RBM25 operates. PD98059, an inhibitor of MEK, can indirectly enhance the function of RBM25 by inhibiting MEK in the MAPK pathway. Y-27632, a selective inhibitor of Rho-associated protein kinases (ROCKs), indirectly enhances the function of RBM25 by modifying protein kinase signaling. Lastly, SB203580, a potent inhibitor of p38 MAPK, indirectly enhances the function of RBM25 by inhibiting p38 MAPK, a pathway in which RBM25 operates.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin, a protein synthesis inhibitor, is known to activate the JNK and p38 MAPK pathways. RBM25, as a RNA binding protein, has been reported to be associated with the MAPK signaling pathway. Therefore, anisomycin, by activating the MAPK pathway, can indirectly enhance the function of RBM25. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a potent inhibitor of the Sarco/Endoplasmic Reticulum Ca2+ ATPase (SERCA). It induces ER stress and activates the unfolded protein response pathway. Since RBM25 is known to be involved in stress response, Thapsigargin can indirectly enhance the function of RBM25 by inducing stress conditions. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is a potent mTOR inhibitor. mTOR signaling is crucial for cellular growth and proliferation, and RBM25 has been reported to interact with components of this pathway. Thus, rapamycin, by inhibiting mTOR, may indirectly enhance the function of RBM25. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase which increases the level of cAMP. cAMP regulates a number of important physiological responses, and RBM25 is known to be involved in cAMP-dependent signaling pathways. Therefore, Forskolin can indirectly enhance the function of RBM25. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is a natural polyphenol that activates Sirtuin 1, an enzyme involved in cellular stress response. As RBM25 is involved in stress response, this can indirectly enhance the function of RBM25. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, can influence various signaling pathways, including the PI3K/Akt pathway. Given that RBM25 functions within this pathway, Genistein by inhibiting tyrosine kinase can indirectly enhance the function of RBM25. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. Given that RBM25 functions within the context of protein kinase signaling, Staurosporine can indirectly enhance the function of RBM25 by altering protein kinase signaling. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor. Altering the acetylation state of histones can influence the expression of downstream genes, including RBM25, thereby indirectly enhancing its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of PI3K, a pathway in which RBM25 is known to function. By inhibiting PI3K, LY294002 can indirectly enhance the function of RBM25. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, a kinase upstream of ERK in the MAPK pathway. RBM25 is known to function within the MAPK pathway, and thus PD98059 can indirectly enhance the function of RBM25. | ||||||